P-025: Investigating the effect of irreversible proteasome inhibitor carfilzomib in in vivo models of cardiometabolic syndrome and early stage HFrEFP: prophylactic role of metformin
Title:
P-025: Investigating the effect of irreversible proteasome inhibitor carfilzomib in in vivo models of cardiometabolic syndrome and early stage HFrEFP: prophylactic role of metformin
Author:
Efentakis, Panagiotis Lamprou, Sofia Varela, Aimilia Papanagnou, Eleni-Dimitra Christodoulou, Andriana Gavriatopoulou, Maria Davos, Costantinos Trougakos, Ioannis P Dimopoulos, Meletios A. Andreadou, Ioanna Terpos, Evangelos